Table 2 Use of anti-malarial drugs during pregnancy
District | Pangani | Tanga | Korogwe | TOTAL | |||
|---|---|---|---|---|---|---|---|
Facility level | District Hospital | Dispensary | District Hospital | Health Centre | District Hospital | Dispensary | |
Respondents per facility | 17 | 13 | 32 | 28 | 19 | 10 | 119 |
Any anti-malarials taken during this pregnancy | |||||||
As treatment, n (%) | 3 (17.7) | 2 (15.4) | 8 (25.0) | 5 (17.9) | 4 (21.1) | 1 (10.0) | 23 (19.3) |
As prevention, n (%) | 12 (70.6) | 9 (69.2) | 12 (37.5) | 14 (50.0) | 11 (57.9) | 9 (90.0) | 67 (56.3) |
Heard of IPTp, n (%) | 14 (82.4) | 11 (84.6) | 19 (59.4) | 24 (85.7) | 18 (94.7) | 10 (100) | 96 (80.7) |
Received any doses IPTp † | |||||||
Overall, n (%) | 9 (52.9) | 7 (53.9) | 11 (34.4) | 15 (53.6) | 14 (73.7) | 9 (90.0%) | 65 (54.6) |
Uptake among those ≥ 5 months gestation* | 64.3% | 77.8% | 40.0% | 62.5% | 100% | 100% | 67.0% |
Received ≥ 2 doses IPTp † | |||||||
Overall, n (%) | 7 (41.2) | 5 (38.5) | 4 (12.5) | 5 (17.9) | 6 (31.6) | 4 (40.0) | 31 (26.1) |
Uptake among those ≥ 7 months gestation** | 87.5% | 75.0% | 16.7% | 30.8% | 85.7% | 66.7% | 48.2% |